Literature DB >> 15962217

Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis.

Stéphane T Temmerman1, Sammy Place, Anne-Sophie Debrie, Camille Locht, Françoise Mascart.   

Abstract

BACKGROUND: Most individuals infected with Mycobacterium tuberculosis do not develop tuberculosis (TB) and can be regarded as being protected by an appropriate immune response to the infection. The characterization of the immune responses of individuals with latent TB may thus be helpful in the definition of correlates of protection and the development of new vaccine strategies. The highly protective antigen heparin-binding hemagglutinin (HBHA) induces strong interferon (IFN)- gamma responses during latent, but not active, TB. Because of the recently recognized importance of CD8(+) T lymphocytes in anti-TB immunity, we characterized the CD8(+) T lymphocyte responses to HBHA in subjects with latent TB.
RESULTS: HBHA-specific CD8(+) T lymphocytes expressed memory cell markers and synthesized HBHA-specific IFN- gamma . They also restricted mycobacterial growth and expressed cytotoxicity by a granule-dependent mechanism. This activity was associated with the intracellular expression of HBHA-induced perforin. Surprisingly, the perforin-producing CD8(+) T lymphocytes were distinct from the IFN- gamma -producing CD8(+) T lymphocytes.
CONCLUSION: During latent TB, the HBHA-specific CD8(+) T lymphocyte population expresses all 3 effector functions associated with CD8(+) T lymphocyte-mediated protective immune mechanisms, which supports the notion that HBHA may be protective in humans and suggests that markers of HBHA-specific CD8(+) T lymphocyte responses may be useful in the monitoring of protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962217     DOI: 10.1086/430930

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Decreased expression of perforin in CD8+ T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment.

Authors:  Hongbin Jiang; Huili Gong; Qing Zhang; Jin Gu; Li Liang; Jun Zhang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.

Authors:  Xindong Teng; Maopeng Tian; Jianrong Li; Songwei Tan; Xuefeng Yuan; Qi Yu; Yukai Jing; Zhiping Zhang; Tingting Yue; Lei Zhou; Xionglin Fan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.

Authors:  Chloé Wyndham-Thomas; Véronique Corbière; Violette Dirix; Kaatje Smits; Fanny Domont; Myriam Libin; Marc Loyens; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

Review 4.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

5.  Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Authors:  Jan Andersson; Arina Samarina; Joshua Fink; Sayma Rahman; Susanna Grundström
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

6.  Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions.

Authors:  Sayma Rahman; Berhanu Gudetta; Joshua Fink; Anna Granath; Senait Ashenafi; Abraham Aseffa; Milliard Derbew; Mattias Svensson; Jan Andersson; Susanna Grundström Brighenti
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

7.  Novel feature of Mycobacterium avium subsp. paratuberculosis, highlighted by characterization of the heparin-binding hemagglutinin adhesin.

Authors:  Louise H Lefrancois; Christelle C Bodier; Thierry Cochard; Sylvie Canepa; Dominique Raze; Philippe Lanotte; Iker A Sevilla; Karen Stevenson; Marcel A Behr; Camille Locht; Franck Biet
Journal:  J Bacteriol       Date:  2013-08-23       Impact factor: 3.490

8.  Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.

Authors:  Chloé Wyndham-Thomas; Violette Dirix; Kinda Schepers; Charlotte Martin; Marc Hildebrand; Jean-Christophe Goffard; Fanny Domont; Myriam Libin; Marc Loyens; Camille Locht; Jean-Paul Van Vooren; Françoise Mascart
Journal:  BMC Infect Dis       Date:  2015-02-14       Impact factor: 3.090

9.  Evaluation of the eukaryotic expression of mtb32C-hbha fusion gene of Mycobacterium tuberculosis in Hepatocarcinoma cell line.

Authors:  Roghayeh Teimourpour; Hosna Zare; Ramazan Rajabnia; Yousef Yahyapour; Zahra Meshkat
Journal:  Iran J Microbiol       Date:  2016-04

10.  Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.

Authors:  Véronique Corbière; Gaelle Pottier; Florence Bonkain; Kinda Schepers; Virginie Verscheure; Sophie Lecher; T Mark Doherty; Camille Locht; Françoise Mascart
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.